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Background: Estimated glomerular filtration rate (eGFR) is a widely used index of kidney 
function. Recently, new formulas such as the Chronic Kidney Disease Epidemiology Col-
laboration (CKD-EPI) equations or the Lund-Malmӧ equation were introduced for assess-
ing eGFR. We compared them with the Modification of Diet in Renal Disease (MDRD) 
Study equation in the Korean adult population.
Methods: The study population comprised 1,482 individuals (median age 51 [42-59] yr, 
48.9% males) who received annual physical check-ups during the year 2014. Serum creat-
inine (Cr) and cystatin C (CysC) were measured. We conducted a retrospective analysis us-
ing five GFR estimating equations (MDRD Study, revised Lund-Malmӧ, and Cr and/or CysC-
based CKD-EPI equations). Reduced GFR was defined as eGFR <60 mL/min/1.73 m2.
Results: For the GFR category distribution, large discrepancies were observed depending 
on the equation used; category G1 (≥90 mL/min/1.73 m2) ranged from 7.4-81.8%. Com-
pared with the MDRD Study equation, the other four equations overestimated GFR, and 
CysC-based equations showed a greater difference (-31.3 for CKD-EPICysC and -20.5 for 
CKD-EPICr-CysC). CysC-based equations decreased the prevalence of reduced GFR by one 
third (9.4% in the MDRD Study and 2.4% in CKD-EPICysC).
Conclusions: Our data shows that there are remarkable differences in eGFR assessment in 
the Korean population depending on the equation used, especially in normal or mildly de-
creased categories. Further prospective studies are necessary in various clinical settings.
Key Words: Estimated glomerular filtration rate, MDRD Study equation, CKD-EPI equa-
tion, Revised Lund-Malmӧ equation
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INTRODUCTION
Early detection of at-risk populations with decreased kidney 
function is important for both acute kidney injury and chronic 
kidney disease (CKD) [1-3]. Glomerular filtration rate (GFR) is 
the most widely used index for assessing kidney function, which 
is implicated in the guidelines for CKD diagnosis and staging [3-
6]. Various equations for estimating GFR (eGFR) have been in-
troduced and are currently used; among them, 83% of clinical 
laboratories used the serum creatinine (Cr)-based Modification 
of Diet in Renal Disease (MDRD) Study equation in the 2013 
College of American Pathologists survey [7]. However, the equa-
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tion was derived from subjects with CKD, and had the limitation 
of systematically underestimating GFR in healthy individuals 
with GFR ≥60 mL/min/1.73 m2 [8, 9]. To overcome this limita-
tion, the Chronic Kidney Disease Epidemiology Collaboration 
equation (CKD-EPICr) was developed in 2009 on the basis of se-
rum Cr, and more accurate calculations for GFRs ≥60 mL/
min/1.73 m2 were made possible [10]. In addition, CKD-EPI 
2012 equations based on cystatin C (CysC) (CKD-EPICysC) or a 
combination of Cr and CysC (CKD-EPICr-CysC) were proposed in a 
standardized assay to better estimate GFR [11, 12]. Another 
new equation, the revised Lund-Malmӧ (LMRevised) equation was 
recently developed, and its performance was reported to be 
more consistent than the MDRD Study and CKD-EPI equations 
[13-15]. However, this equation was derived from only a Swed-
ish Caucasian population.
There have been several reports that compared the MDRD 
Study and CKD-EPI equations in the general population [16-20]; 
however, only a few studies have included the CysC-containing 
equations. In this study, we compared five eGFR equations 
(MDRD Study equation, LMRevised equation, and three CKD-EPI 
equations) to explore the differences in the equations across the 
GFR categories in Korean adults.
METHODS
1. Study population
During the year 2014, the recipients of annual physical check-
ups at the Gangnam branch of Korean Association of Health 
Promotion (KAHP, Seoul, Korea) were consecutively included 
according to the following criteria: over 30 yr old and presence 
of serum Cr and/or CysC results. There were no exclusion crite-
ria for the subject selection process. KAHP is a specialized 
health-screening center, which provides routine medical check-
ups to over 1,000,000 individuals annually in 16 branch clinics 
nationwide in Korea. 
The number of subjects with serum Cr and CysC results was 
1,482 (51 [42-59] yr, 48.9% males). Besides serum Cr and/or 
CysC results, lipid profiles and HbA1c levels were also collected. 
We conducted a retrospective analysis of laboratory data using 
the five eGFR equations, and this study was approved by the 
Institutional Review Board of KAHP.
2. Estimation of GFR
GFR (mL/min/1.73 m2) was estimated by using five different 
equations (MDRD Study, LM revised, and three CKD-EPI equa-
tions) as follows:
a) Four-variable MDRD Study equation [9], GFR=175×sCr 
-1.154 ×Age-0.203 ×0.742 (if female);
b) LMRevised equation [13], GFR=eX-0.0158×Age+0.438×ln(Age), where 
ln is natural logarithm and X=2.50+0.0121×(150-sCr) for fe-
males with sCr level <150 μmol/L, 2.50-0.926×ln (sCr/150) for 
females with sCr level ≥150 μmol/L, 2.56+0.00968×(180-sCr) 
for males with sCr level <180 μmol/L, and 2.56-0.926 ×ln 
(sCr/180) for males with sCr level ≥180 μmol/L;
c) CKD-EPICr equation [10], GFR=141×min (sCr/κ, 1)α× 
max (sCr/κ, 1)-1.209 ×0.993Age ×1.018 [if female], where sCr is 
serum creatinine, κ is 0.7 for females and 0.9 for males, α is 
-0.329 for females and -0.411 for males, min is the minimum of 
sCr/κ or 1, and max is the maximum of sCr/κ or 1;
d) CKD-EPICysC equation [11], GFR=133×min (sCysC/0.8, 1) 
-0.499 ×max (sCysC/0.8, 1)-1.328 ×0.996Age ×0.932 [if female], where 
sCysC is serum cystatin C, min indicates the minimum of sCysC/ 
0.8 or 1, and max indicates the maximum of sCysC/0.8 or 1;
e) CKD-EPICr-CysC equation [11], GFR=135×min (sCr/κ, 1)α× 
max (sCr/κ, 1)-0.601 ×min (sCysC/0.8, 1)-0.375 ×max (sCysC/0.8, 
1)-0.711 ×0.995Age ×0.969 [if female], where Scr is serum creati-
nine, sCysC is serum cystatin C, κ is 0.7 for females and 0.9 for 
males, α is -0.248 for females and -0.207 for males. 
Serum Cr levels were determined by the kinetic Jaffe method 
using SICDIA CRE reagent (Shinyang Chemical, Seoul, Korea) 
on an automated chemistry analyzer (HITACHI 7600-110; Hita-
chi High-Technologies Co., Tokyo, Japan). Isotope-dilution mass 
spectrometry (IDMS)-traceable calibration was conducted weekly 
with a C.f.a.s. calibrator (Roche Diagnostics, Indianapolis, IN, 
USA). For internal quality control in the Cr assay, two levels of Ly-
phochek assayed chemistry quality control materials (Bio-Rad, 
Hercules, CA, USA) were tested once a day. The mean within-
laboratory precision of the serum Cr assay was 2.1% during the 
study period. The laboratory participated in the external 
proficiency testing program organized by the Korean Association 
of Quality Assurance for Clinical Laboratory, and the results were 
all acceptable (variance index scores <150) during 2014.
Serum CysC levels were measured by the latex immunoturbi-
dimetric method using Sekisui reagent (Sekisui Chemical, To-
kyo, Japan) on the same analyzer. The reagent was traceable to 
the European Reference Material DA471/IFCC. Two levels of 
Liquichek Immunology Control materials (Bio-Rad) were tested 
once a day. The mean within-laboratory precision of the serum 
CysC assay was 1.4% during the study period. The inter-labora-
tory comparison was performed for CysC, and the differences in 
results between the two locations were within 10%. All mea-
surements were performed according to the manufacturer’s in-
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structions and standard laboratory procedures. 
3. GFR categories
GFRs were categorized into ≥90 (G1), 60-89 (G2), 45-59 (G3a), 
30-44 (G3b), 15-29 (G4), and <15 (G5) mL/min/1.73 m2 ac-
cording to the Kidney Disease Improving Global Outcomes 
(KDIGO) 2012 guideline [4]. The prevalence of reduced GFR, 
defined as eGFR <60 mL/min/1.73 m2, was compared among 
the equations on the basis of the levels of serum Cr, CysC, or 
both [4].
4. Statistical analyses
The eGFRMDRD was regarded as the comparative GFR for com-
parisons. Bland-Altman plots were used to identify mean differ-
ences and 95% limits of agreement of eGFRs between each 
equation and the MDRD Study equation. Pearson’s correlation 
coefficients (r) were calculated to compare the equations. r co-
efficients ≤0.35 were considered low or weak correlations; 
0.36-0.67, modest or moderate correlations; and 0.68-1.0, 
strong or high correlations; with r coefficients ≥0.90 being very 
high correlations [21].
Categorical agreement rates were calculated when eGFRMDRD 
and eGFR based on other equations were within the same GFR 
categories. Weighted kappa value was determined to evaluate 
the degree of categorical agreement, and kappa value was de-
termined for diagnostic agreement with GFR cutoffs of 60 mL/
min/1.73 m2 and 45 mL/min/1.73 m2 [4]. The kappa values 
were interpreted as follows: <0.20, poor; 0.21-0.40, fair; 0.41-
0.60, moderate; 0.61-0.80, good; and >0.81, very good [22]. 
In general, reduced GFR is defined as an eGFR <60 mL/
min/1.73 m2. Additionally, the KDIGO guideline recommends 
measuring CysC in adults with an eGFRCr of 45-59 mL/min/1.73 
m2, who do not have markers of kidney damage for confirma-
tion of CKD [4]. Thus, we used two GFR cutoff points. The over-
all concordance rate (positive and negative) was also calculated 
for all equations. 
Data were analyzed by using Analyse-it (Analyse-it Software 
Ltd., Leeds, UK) and MedCalc Statistical Software version 
15.2.2 (MedCalc Software, Ostend, Belgium). P values ≤0.05 
were considered statistically significant.
RESULTS
1. GFR category distribution in the study population
The baseline subject characteristics and calculated eGFR strati-
fied by age groups are shown in Table 1. The CKD-EPI equa-
tions yielded higher mean eGFRs than the MDRD Study equa-
tion, and the degree of difference varied with the equations and 
Table 1. Baseline subject characteristics and estimated glomerular filtration rates stratified by age group 
Variables 30-39 yrN=275
40-49 yr
N=412
50-59 yr
N=432
60-69 yr
N=289
70-79 yr
N=74
Total
N=1,482
Male % 46.7 55.0 45.4 47.4 49.0 48.9 
Age (yr) 35 (32-38) 44 (42-46) 54 (52-57) 63(61-66) 72 (70-75) 51 (42-59)
Body mass index (kg/m2) 22.9±3.8 23.7±3.6 23.6±3.1 23.9±2.9 24.0±3.2 23.6±3.4
HbA1c (%)* 5.3±0.4 5.6±1.0 5.7±0.8 6.0±1.0 6.2±1.5 5.7±0.9
Total cholesterol (mg/dL) 190±44 198±46 204±71 202±78 195±55 199±61
Triglyceride (mg/dL) 95±82 117±102 101±78 102±62 106±57 105±83
HDL-cholesterol (mg/dL) 51±14 49±13 51±17 50±19 49±15 50±16
LDL-cholesterol (mg/dL) 116±32 123±33 133±54 134±62 122±41 127±47
Serum Cr (mg/dL) 0.95±0.20 0.97±0.17 0.96±0.23 0.99±0.35 1.03±0.25 0.97±0.24
Serum CysC (mg/L) 0.71±0.14 0.73±0.13 0.78±0.15 0.86±0.21 0.96±0.23 0.78±0.17
eGFRMDRD (mL/min/1.73 m2) 80.1±12.0 75.4±10.2 72.0±10.8 68.9±12.6 64.4±14.4 73.5±12.2
eGFRLM revised (mL/min/1.73 m2) 82.9±9.8 78.6±8.8 73.2±9.2 66.8±10.7 58.9±11.9 74.5±11.6
eGFRCKD-EPI Cr (mL/min/1.73 m2) 92.1±13.6 85.2±11.7 79.1±11.8 73.0±13.2 65.8±15.0 81.4±14.5
eGFRCKD-EPI CysC (mL/min/1.73 m2) 117.8±12.7 112.5±12.4 102.5±14.1 91.0±17.3 79.5±19.1 104.7±18.0
eGFRCKD-EPI Cr-CysC (mL/min/1.73 m2) 106.1±13.1 99.9±11.8 91.7±12.1 82.7±14.6 73.2±16.8 94.0±15.9
All data except male % and age are expressed as mean±standard deviation. Age is presented as median value (25th and 75th percentiles).
*HbA1c was measured in 1,082 participants. 
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal 
Disease; LM, Lund-Malmӧ; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; Cr, creatinine; CysC, cystatin C. 
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Table 2. Frequency of glomerular filtration rate categories by five estimating equations 
GFR category 
   (mL/min/1.73 m2)
Number (%) of subjects with each GFR category according to the estimating equations
MDRD  CKD-EPICr CKD-EPICysC CKD-EPICr-CysC LMrevised
G1 ≥90 119 (8.0) 416 (28.0) 1,212 (81.8) 982 (66.2) 109 (7.4)
G2 60-89 1,224 (82.5) 983 (66.3) 235 (15.8) 461 (31.1) 1,254 (84.6)
G3a 45-59 112 (7.5) 58 (3.9) 24 (1.6) 26 (1.8) 92 (6.2)
G3b 30-44 20 (1.3) 18 (1.2) 10 (0.7) 11 (0.7) 14 (0.9)
G4 15-29 6 (0.4) 6 (0.4) 1 (0.0) 2 (0.1) 12 (0.8)
G5 <15 1 (0.1) 1 (0.1) 0 (0.0) 0 (0.0) 1 (0.1)
Total 1,482 (100.0) 1,482 (100.0) 1,482 (100.0) 1,482 (100.0) 1,482 (100.0)
Abbreviations: GFR, glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; LM, Lund-Malmӧ; CKD-EPI, Chronic Kidney Disease 
Epidemiology Collaboration; Cr, creatinine; CysC, cystatin C.
Table 3. Agreement between MDRD Study equation and other equations 
GFR 
category
MDRD Study Categorical agreement 
Diagnostic agreement at specific 
eGFR cutoffs
G1 G2 G3a G3b G4 G5 Total %
Weighted 
kappa 
(95% CI)
Kappa at 60 
mL/min/1.73 m2 
(95% CI)
Kappa at 45 
mL/min/1.73 m2 
(95% CI)
CKD-EPICr G1 119 297 0 0 0 0 416 76.0 0.521 0.729 0.961 
G2 0 927 56 0 0 0 983 (0.474-0.568) (0.662-0.796) (0.907-1.000)
G3a 0 0 56 2 0 0 58
G3b 0 0 0 18 0 0 18
G4 0 0 0 0 6 0 6
G5 0 0 0 0 0 1 1
CKD-EPICysC G1 113 1,047 43 7 2 0 1,212 20.3 0.067 0.259 0.415 
G2 4 169 54 4 4 0 235 (0.047-0.087) (0.173-0.346) (0.217-0.613)
G3a 2 7 13 2 0 0 24
G3b 0 1 2 6 0 1 10
G4 0 0 0 1 0 0 1
G5 0 0 0 0 0 0 0
CKD-EPICr-CysC G1 113 865 4 0 0 0 982 33.3 0.139 0.402 0.595 
G2 6 358 92 5 0 0 461 (0.111-0.167) (0.313-0.492) (0.415-0.776)
G3a 0 1 15 7 3 0 26
G3b 0 0 1 7 3 0 11
G4 0 0 0 1 0 1 2
G5 0 0 0 0 0 0 0
LMrevised G1 103 6 0 0 0 0 109 93.8 0.823 0.737 0.962 
G2 16 1,197 41 0 0 0 1,254 (0.788-0.859) (0.674-0.799) (0.910-1.000)
G3a 0 21 70 1 0 0 92
G3b 0 0 1 13 0 0 14
G4 0 0 0 6 6 0 12
G5 0 0 0 0 0 1 1
Total 119 1,224 112 20 6 1 1,482
Abbreviations: CI, confidence interval; See Table 1.
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age groups. The eGFRCKD-EPI CysC (104.7 mL/min/1.73 m2) was 
the highest, followed by eGFRCKD-EPI Cr-CysC (94.0 mL/min/1.73 
m2), eGFRCKD-EPI Cr (81.4 mL/min/1.73 m2), eGFRLM Revised (74.5 
mL/min/1.73 m2), and eGFRMDRD (73.5 mL/min/1.73 m2). In 
older patients (≥  60 yr), the LMRevised equation yielded a lower 
eGFR than the MDRD Study equation. For all equations, a de-
creasing eGFR trend was observed as age increased.
The frequencies of the subjects in each GFR category are 
shown in Table 2. The proportion of each GFR category varied 
considerably between equations, especially for categories G1 
and G2. The proportions of G1 were 8.0% (MDRD), 28.0% 
(CKD-EPICr), 81.7% (CKD-EPICysC), 66.2% (CKD-EPICr-CysC), and 
7.4% (LMRevised), and the proportions of G2 were 82.5% (MDRD), 
66.3% (CKD-EPICr), 15.8% (CKD-EPICysC), 31.1% (CKD-EPICr-CysC), 
and 84.6% (LMRevised). 
2.  Concordance between MDRD Study equation and other 
equations
Categorical agreement rates between the MDRD Study and 
other equations ranged from 20.3 to 93.8%. Upward reclassifi-
cation from G2 (MDRD Study equation) to G1 (CKD-EPI equa-
tions) was common, especially for CKD-EPICysC and CKD-EPICr-
CysC equations (Table 3). Weighted kappa values were fair to 
good in serum Cr-based equations, but poor in CysC-containing 
equations.
For diagnostic agreement, kappa values at two eGFR cutoffs 
were variable depending on the equation. Kappa values were 
better at cutoff 45 mL/min/1.73 m2 than 60 mL/min/1.73 m2. 
For all equations, overall concordance rates were greater than 
90% when the GFR cutoff of 60 mL/min/1.73 m2 was used 
(96.2% for CKD-EPICr, 91.6% for CKD-EPICysC, 93.1% for CKD-
EPICr-CysC, and 95.8% for LMRevised), or when 45 mL/min/1.73 m2 
was used (99.9% for CKD-EPICr, 98.5% for CKD-EPICysC, 98.9% 
for CKD-EPICr-CysC, and 99.9% for LMRevised). 
The mean eGFR difference (calculated by: GFR by MDRD 
Study equation-GFR by other equations) was largest in the CKD-
EPICysC equation (-31.4, Fig. 1); it was significantly larger than 
the differences of other equations compared with the MDRD 
Study equation (P <0.001). The r coefficients were 0.936 for 
LMRevised, 0.972 for CKD-EPICr, 0.494 for CKD-EPICysC, and 0.806 
for CKD-EPICr-CysC equations (P <0.001).
3. Prevalence of reduced eGFR 
The prevalence of reduced GFR (<60 mL/min/1.73 m2, which 
corresponds to GFR categories G3a-G5) according to the age 
group and gender are presented in Table 4. In total, the preva-
lence of reduced GFR was the highest according to the MDRD 
Study equation (9.4%) and the lowest (2.4%) according to the 
CKD-EPICysC equation. The prevalence increased as age in-
creased in all equations. Of note, a very high percentage of low 
GFR (45.9%) was noted in patients in their 70’s according to 
the LMRevised equation. 
DISCUSSION
The Cr-based CKD-EPI equation is recommended for the initial 
assessment of GFR, and CysC-based CKD-EPI equations can 
be used for confirmation of kidney disease according to the 
KDIGO guidelines [4, 23]. In this study, we compared five eGFR 
equations, including CysC-based formulas, in the Korean popu-
lation. The prevalence of reduced GFR by CysC-based CKD-EPI 
equations has not been reported in Korea yet.
The eGFR classification differed considerably according to the 
equation used for estimation, especially between CKD-EPICysC or 
CKD-EPICr-CysC equations compared with the MDRD Study equa-
tion. Most of the study population (>80%) were in the G2 cate-
gory (60-89 mL/min/1.73 m2) according to the MDRD Study 
equation, but in G1 (≥90 mL/min/1.73 m2) according to the 
CKD-EPICysC equation. The reason for this discrepancy might be 
related to the eGFR distribution of the study population. Mean 
eGFRMDRD was 73.5 mL/min/1.73 m2 with a standard deviation 
of 12.2 mL/min/1.73 m2; thus, there were many results around 
the cutoff value of 90 mL/min/1.73 m2. In addition, the CKD-
EPICysC and CKD-EPICr-CysC equations yielded systematically 
higher eGFR results (mean difference 31.4 mL/min/1.73 m2 
and 20.6 mL/min/1.73 m2, respectively) in comparison with the 
MDRD Study equation. This finding was in line with previous 
studies. In the US National Health and Nutrition Examination 
Survey (NHANES) 1999-2002 data, the distribution of eGFRCKD-
EPI CysC was broader and shifted to the right compared with that 
of eGFRMDRD [24]. Thus, upward reclassification might be com-
mon in CysC-based equations.
All equations, except for the CKD-EPICysC equation, showed 
good correlation with the MDRD Study equation. CKD-EPICysC 
showed only a moderate correlation (r=0.49). The three differ-
ent CKD-EPI equations showed an overall low prevalence of re-
duced GFR compared with the MDRD Study equation, espe-
cially according to the two CysC-containing equations. The LM-
Revised equation was recently reported to outperform the MDRD 
Study and CKD-EPI equations in a Swedish population [15]; 
however, there has been no evaluation of this equation in the 
Asian population. It yielded similar mean eGFR results com-
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pared with the MDRD Study equation; these two equations 
showed a very high correlation and a similar prevalence of re-
duced GFR. However, eGFR was underestimated in patients ≥ 
60 yr, when using the LMRevised equation. This observation needs 
to be subjected to further studies because of the increased pos-
sibility of co-morbidities in older patients. The LMRevised equation 
was generated only from the Swedish population; hence, ethnic 
differences might have influenced GFR estimation as well.
Although the CKD-EPICr equation is recommended by KDIGO 
for initial GFR assessment, newer GFR estimating equations 
have been developed and validated, including a Korean version 
of the CKD-EPICr equation [25], a serum Cr-based full age spec-
trum equation [26], and a CysC-based equation based on a 
Caucasian, Asian, pediatric, and adult population (CAPA) [27]. 
Our study did not aim to compare all recent equations; however, 
we analyzed the CysC-based CAPA equation briefly. The mean 
eGFRCAPA (106.3 mL/min/1.73 m2), eGFR difference in compari-
son with MDRD Study equation (-32.9), and prevalence of 
eGFR less than 60 mL/min/1.73 m2 (2.7%) were similar when 
compared with CKD-EPICysC equation. 
The prevalence of reduced GFR has been reported differently 
depending on the study population and the GFR-estimating 
equation used. In several previous studies, there were clinically 
significant differences in the prevalence of stage 3 or higher 
CKD depending on the equation used to estimate GFR. Dela-
naye et al [20] reported that the prevalence of eGFR less than 
60 mL/min/1.73 m2 was the highest for eGFRMDRD (13%), inter-
mediate for eGFRCKD-EPI Cr (9.8%), and the lowest for eGFRCKD-EPI 
Fig. 1. Bland-Altman plots of estimated glomerular filtration rate (eGFR) calculated by the MDRD Study equation and others (n=1,482). 
(A) CKD-EPICr equation. (B) LMRevised equation. (C) CKD-EPICysC equation. (D) CKD-EPICr-CysC equation. The solid gray lines represent the 
mean difference and dashed lines depict±1.96 SD. A negative difference suggests an overestimation of GFR by each equation compared 
with the value obtained by the MDRD Study equation. For ease of display, the maximum scale on the vertical axis of (A) and (B) was limited 
to 30, while that on (C) and (D) was limited to 90 depending on the distribution of the eGFR difference between equations.
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Cr-CysC (5%) and eGFRCKD-EPI CysC (4.7%) in 4,189 Belgian patients 
over 50 yr old. This prevalence trend was similar to ours. One 
Japanese study showed a 2-fold difference of prevalence be-
tween the MDRD Study and CKD-EPICr equations (12.8 vs 
6.5%), by studying over 26,000 participants who underwent 
annual health check-ups [16]. Lujambio et al [28] reported that 
the prevalence of eGFR less than 60 mL/min/1.73 m2 was the 
highest for eGFRCKD-EPI CysC (21.8%), intermediate for eGFRCKD-EPI 
Cr-CysC (11.8%), and the lowest for eGFRMDRD (5.9%) and eG-
FRCKD-EPI Cr (3.4%) in 119 Uruguayans. 
In the US, the prevalence of reduced GFR (eGFR <60 mL/
min/1.73 m2) by CKD-EPICr equation was reported to be 4.7% 
from 1988-1994 and 6.5% from 1999-2002 from NHANES 
data [29]. In Korea, the prevalence of reduced GFR by the 
CKD-EPICr equation has been reported as 7.7% in 2007 and 
2.6% in 2010 from Korea NHANES data [17, 18]. In this study, 
it was 5.1% of the whole study population. This difference could 
be due to the following reasons. First, the proportion of younger 
individuals under 40 yr old was lower than that in other studies 
(23% vs 30-32%). Compared with 2010 Korea NHANES data, 
the mean eGFR was relatively lower in this study (81.4 mL/
min/1.73 m2 vs 95.9-96.8 mL/min/1.73 m2), resulting in higher 
prevalence of reduced GFR compared with other studies. Sec-
ond, the study period was different (2014 vs 2007-2010), al-
though the impact of this on the prevalence is still uncertain.
Our retrospective study has several limitations. First, we com-
pared all the eGFR equations to the MDRD Study equation, be-
cause of the absence of GFR data measured by the gold stan-
dard method [18]. Therefore, it was impossible to evaluate the 
accuracy. The magnitude of bias, calculated by measured GFR-
calculated GFR was previously reported to be 2.5-5.8 mL/
min/1.73 m2, and this difference could influence the prevalence 
of CKD stages [17, 24]. Second, our population might not be 
representative of the entire population of Korea. Third, we could 
not analyze albuminuria data or other markers of kidney dam-
age. The classification of CKD was not performed, which is 
based on both GFR category and albuminuria category. Thus, 
there could be the CKD patients among the subjects with eGFR 
≥60 mL/min/1.73 m2.
In conclusion, this is the first study that compared five eGFR 
equations in the Korean population. Our data demonstrated re-
markable differences in GFR assessment depending on the 
equation used. The proportion of each GFR category varied 
considerably, and CysC-containing equations yielded higher eG-
FRs and showed larger differences compared with the MDRD 
Study equation. The prevalence of reduced GFR was lowered 
by the CKD-EPI equations. Further studies using prospective 
design and in various ethnicities are necessary.
Table 4. Prevalence of reduced eGFR ( <60 mL/min/1.73 m2) 
based on the five equations, stratified by age group and sex*
Age (yr)
Number (%) of subjects with reduced eGFR by each equation
Total (n=1,482) Male (n=725)     Female (n=757)    
MDRD 
   30-39  6 (2.2) 2 (1.6) 4 (2.7) 
   40-49  17 (4.1) 8 (3.5) 9 (4.9) 
   50-59 46 (10.6) 21 (10.7) 25 (10.6) 
   60-69 45 (15.6) 17 (12.4) 28 (18.4) 
   70-79 25 (33.8) 10 (27.8) 15 (39.4) 
   Total 139 (9.4) 58 (8.0) 81 (10.7) 
LMrevised 
   30-39 2 (0.7) 1 (0.8) 1 (0.7) 
   40-49 6 (1.5) 2 (0.9) 4 (2.2) 
   50-59 24 (5.6) 17 (8.7) 7 (3.0) 
   60-69 53 (18.3) 29 (21.2) 24 (15.8) 
   70-79 34 (45.9) 16 (44.4) 18 (47.4) 
   Total 119 (8.0) 65 (9.0) 54 (7.1) 
CKD-EPICr 
   30-39 2 (0.7) 1 (0.8) 1 (0.7) 
   40-49 6 (1.5) 2 (0.9) 4 (2.2) 
   50-59 16 (3.7) 9 (4.6)  7 (3.0) 
   60-69 34 (11.8) 17 (12.4) 17 (11.2) 
   70-79 25 (33.8) 10 (27.8) 15 (39.5) 
   Total 83 (5.6) 39 (5.4) 44 (5.8) 
CKD-EPICysC 
   30-39 2 (0.7) 0 (0.0) 2 (1.4) 
   40-49 1 (0.2) 1 (0.4) 0 (0.0) 
   50-59 7 (1.6) 5 (2.6) 2 (0.8) 
   60-69 14 (4.8) 9 (6.6) 5 (3.3) 
   70-79 11 (14.9) 7 (19.4) 4 (10.5) 
   Total 35 (2.4) 22 (3.0) 13 (1.7) 
CKD-EPICr-CysC 
   30-39 2 (0.7) 1 (0.8) 1 (0.7) 
   40-49 0 (0.0) 0 (0.0) 0 (0.0) 
   50-59 7 (1.6) 7 (3.6) 0 (0.0) 
   60-69 15 (5.2) 9 (6.6) 6 (3.9) 
   70-79 15 (20.3) 7 (19.4) 8 (21.1) 
   Total 39 (2.6) 24 (3.3) 15 (2.0) 
*GFR categories G3a-G5 correspond to GFR <60 mL/min/1.73 m2. 
Abbreviations: See Table 1.
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